Company Email Format Management

Herantis Pharma Plc.

Biotechnology Research Espoo, Uusimaa, Fi 24 employees FIRST

Employees: 24
Contacts: 2
Emails: 2
Phones: 1

herantis.com LinkedIn Crunchbase

Herantis Pharma Plc. Overview

Headquarters: Espoo, Uusimaa, Fi
Phone Number: Available in AeroLeads
Website: herantis.com
Industry: Biotechnology Research
Employees: 24
Founded: 2008
Stock Symbol: FIRST
Funding: 5.4M
Company Email: Available in AeroLeads
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

Parkinson's disease Neurodegenerative diseases Biologics biotech drug development

About Herantis Pharma Plc.

Herantis Pharma Plc is a clinical-stage biotechnology company developing disease modifying therapies for Parkinson’s disease. Herantis’s lead product, HER-096 is a first-in-class agent in development for the treatment of Parkinson’s disease with disease modifying potential and convenient subcutaneous administration. Primary objective of the ongoing Phase 1b clinical trial is to assess the safety, tolerability and pharmacokinetics of repeated subcutaneous doses of HER-096; the trial will also evaluate selected biomarkers and monitor symptoms associated with Parkinson’s disease. Topline data from Phase 1b trial is expected in September 2025. The Phase 1b trial is funded by the Michael J. Fox Foundation for Parkinson’s Research (MJFF) and The Parkinson’s Virtual Biotech. Herantis is listed on the Nasdaq First North Growth Market Finland.

Herantis Pharma Plc. Contact Details

People in AeroLeads: 3
With contact data: 2
Email contacts: 2; 66.7% coverage
Phone contacts: 1; 33.3% coverage

Herantis Pharma Plc. Org Chart

Sample employees and titles

Name	Title	Location	Contact
Henri Huttunen		Espoo, Uusimaa, Finland	Email
Aki Prihti		Helsinki, Uusimaa, Finland	View
Hilde Furberg	Board Member and Advisor	Copenhagen, Capital Region of Denmark, Denmark	Email Phone